Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 9,390 Integer Holdings Corporation $ITGR

Key Points

• Connor Clark & Lunn Investment Management purchased 9,390 shares of Integer Holdings in the second quarter, valued at approximately $877,000. Institutional investors collectively own 99.29% of the company.
• Analyst sentiment remains cautious, with one Buy rating and 13 Hold ratings; the consensus price target is $109.86, below the stock’s reported $125.30 price.
• Integer exceeded quarterly expectations, reporting $1.60 in EPS versus the $1.38 consensus and $464.11 million in revenue, although revenue declined 2.6% year over year.

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Integer Holdings Corporation (NYSE:ITGR - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 9,390 shares of the medical equipment provider's stock, valued at approximately $877,000.

Other hedge funds have also bought and sold shares of the company. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in shares of Integer in the second quarter valued at approximately $29,000. EverSource Wealth Advisors LLC increased its stake in Integer by 48.1% in the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider's stock valued at $32,000 after acquiring an additional 117 shares during the last quarter. TD Private Client Wealth LLC lifted its stake in Integer by 1,037.5% during the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider's stock worth $36,000 after purchasing an additional 415 shares during the last quarter. Parkside Financial Bank & Trust increased its stake in shares of Integer by 135.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider's stock valued at $36,000 after purchasing an additional 267 shares during the last quarter. Finally, Arax Advisory Partners boosted its stake in Integer by 2,489.5% in the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider's stock valued at $39,000 after buying an additional 473 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on ITGR. Citigroup boosted their target price on shares of Integer from $92.00 to $96.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 8th. Wells Fargo & Company lifted their target price on Integer from $84.00 to $127.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 4th. KeyCorp cut Integer from an "overweight" rating to a "sector weight" rating in a report on Monday, August 3rd. Freedom Capital downgraded shares of Integer from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 4th. Finally, HC Wainwright restated a "buy" rating on shares of Integer in a research report on Friday, July 24th. One analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $109.86.

Integer Trading Down 0.0%

NYSE:ITGR opened at $125.30 on Monday. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $126.14. The company has a market cap of $4.26 billion, a PE ratio of 34.24, a PEG ratio of 2.96 and a beta of 0.61. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. The firm has a 50-day moving average of $107.58 and a 200-day moving average of $94.54.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, topping analysts' consensus estimates of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm had revenue of $464.11 million during the quarter, compared to analyst estimates of $451.07 million. During the same period in the previous year, the company posted $1.55 EPS. The company's revenue for the quarter was down 2.6% on a year-over-year basis. As a group, equities research analysts expect that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source